Debate rages over Alzheimer's drug lecanemab as UK limits approval. Kwon D. Nature 2024 Aug 22. doi: 10.1038/d41586-024-02720.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kwon D. Debate rages over Alzheimer's drug lecanemab as UK limits approval. Nature 2024 Aug 22. doi: 10.1038/d41586-024-02720.
PMID: 39179772